Yaseen Rehab Ibrahim, El-Leboudy Mohamed Hesham, El-Deeb Hend Mohammed
Faculty of Medicine, Menoufia University, Abdelrahman Elsharkawey St., Shebin Elkom, Menoufia, Egypt.
Shebin Elkom Teaching Hospital, Shebin Elkom, Egypt.
Egypt Heart J. 2021 Mar 16;73(1):24. doi: 10.1186/s43044-021-00150-z.
Apolipoprotein B is considered the primary protein constituent of low-density lipoprotein. LDL contains variable quantities of cholesterol, but each lipoprotein contains a single ApoB protein. Thus, ApoB is a better index for the LDL circulation if compared to LDL cholesterol. On the contrary, apolipoprotein A-1 is a main structural protein of high-density lipoprotein. It has a major role in reversing cholesterol flow and cellular cholesterol homeostasis once detected. The aim of the study is to measure apo B/apo A-1 ratio in patients with acute coronary syndrome and assess its relationship with the severity of CAD. A total of 90 patients were enrolled in the study and subdivided into 3 groups: 30 patients of STEMI, 30 patients of NSTEMI, and 30 patients presented with unstable angina. Serum levels of apolipoprotein A-1 and apolipoprotein B were properly measured upon admission, and apo B/apo A-1 ratio was calculated.
Both of Apo B and Apo B/Apo A1 ratio correlated significantly with Gensini scores (P value <0.001). High Gensini score patients had significantly high Apo B/Apo A1 ratio with the best cutoff value of 0.8 with sensitivity of 90% and specificity of 70%.
Apo B is an independent risk predictor for the severity of CAD in patients with acute coronary syndromes. Moreover, the Apo B/Apo A1 ratio remains highly significant in patients with high Gensini score.
载脂蛋白B被认为是低密度脂蛋白的主要蛋白质成分。低密度脂蛋白含有不同量的胆固醇,但每个脂蛋白含有单一的载脂蛋白B蛋白。因此,与低密度脂蛋白胆固醇相比,载脂蛋白B是更好的低密度脂蛋白循环指标。相反,载脂蛋白A-1是高密度脂蛋白的主要结构蛋白。一旦被检测到,它在逆转胆固醇流动和细胞胆固醇稳态方面起主要作用。本研究的目的是测量急性冠状动脉综合征患者的载脂蛋白B/载脂蛋白A-1比值,并评估其与冠心病严重程度的关系。共有90名患者纳入本研究,并分为3组:30名ST段抬高型心肌梗死患者、30名非ST段抬高型心肌梗死患者和30名不稳定型心绞痛患者。入院时适当测量载脂蛋白A-1和载脂蛋白B的血清水平,并计算载脂蛋白B/载脂蛋白A-1比值。
载脂蛋白B和载脂蛋白B/载脂蛋白A1比值均与Gensini评分显著相关(P值<0.001)。高Gensini评分患者的载脂蛋白B/载脂蛋白A1比值显著升高,最佳临界值为0.8,敏感性为90%,特异性为70%。
载脂蛋白B是急性冠状动脉综合征患者冠心病严重程度的独立风险预测指标。此外,载脂蛋白B/载脂蛋白A1比值在高Gensini评分患者中仍然具有高度显著性。